United States Bioprocess Technology Market to Reach US$ 62.4 Billion by 2031, Driven by Surging Demand for Biologics and Advanced Single-Use Systems

Leander, Texas and TOKYO, Japan - Dec.3.2025 "Bioprocess Technology Market is anticipated to grow at high CAGR during the forecast period 2024-2031."

The Bioprocess Technology Market is experiencing significant expansion due to the increasing demand for monoclonal antibodies, recombinant proteins, and cell & gene therapies. Market growth is underpinned by technological advancements in single use systems, continuous bioprocessing, and process automation, alongside substantial R&D investments from both established pharmaceutical companies and emerging biotechs.

➠ Download Your Sample Report Instantly - Corporate Email ID Required for Priority Access:
https://www.datamintelligence.com/download-sample/bioprocess-technology-market?praneetha

☛ Recent Industry Developments :
United States :
✅ December 2025: Thermo Fisher Scientific Inc. broke ground on a new $150 million bioprocess consumables manufacturing campus in North Carolina. The facility will focus on producing advanced single use bioreactor bags and custom fluid transfer assemblies, creating over 300 specialized manufacturing jobs.

✅ November 2025: Repligen Corporation received FDA recognition for its next-generation continuous chromatography system following a successful pilot at a major Boston based CDMO. The system demonstrated a 40% reduction in processing time for monoclonal antibody purification.

✅ October 2025: Merck announced a strategic partnership with the U.S. Department of Energy to develop AI-optimized microbial strains for recombinant protein production. The $65 million joint initiative aims to enhance yield and stability in industrial scale bioprocessing.

Global :
✅ December 2025: Sartorius (Germany) and a consortium of European biotech firms launched an €80 million initiative to standardize single-use bioprocessing equipment across 15 manufacturing sites, aiming to improve supply chain resilience and interoperability.

✅ November 2025: Cytiva (UK) and Samsung Biologics (South Korea) inaugurated a $110 million collaborative training center in Incheon, focused on advanced bioprocess workforce development and continuous biomanufacturing implementation.

✅ October 2025: Roche Diagnostics (Switzerland) completed the acquisition of a Canadian bioprocess analytics startup for $75 million, integrating real-time metabolite monitoring and machine learning based predictive control into its bioreactor portfolio.

☛ Core Catalysts Behind Market Growth :
The surging development and commercialization of complex biologics, including cell and gene therapies, is creating unprecedented demand for advanced and flexible bioprocessing solutions.

Accelerated adoption of single use technologies (SUT) to reduce contamination risks, lower capital investment, and increase operational flexibility in multi-product facilities.

Stringent regulatory requirements for product quality and consistency are driving investments in advanced bioprocess analyzers and integrated process control systems.

Growing outsourcing of bioproduction to Contract Manufacturing Organizations (CMOs & CDMOs), which are heavily investing in state of the art bioprocess infrastructure.

Continuous technological evolution towards integrated, automated, and data intensive biomanufacturing platforms to improve yield, reduce costs, and shorten time to market.

➠ Get Customization in the Report as per Your Requirements:
https://www.datamintelligence.com/customize/bioprocess-technology-market?praneetha

☛ Market Segmentation :
By Product Type :
Bioreactors/Fermenters dominate with 45% share, driven by their indispensable role in scalable cell culture and microbial fermentation for biologics and vaccine production.

Instruments (including chromatography, filtration, and centrifugation systems) account for 25%, essential for downstream purification and process efficiency.

Bioprocess Analyzers hold 15%, growing rapidly due to increasing demand for real-time monitoring and process control in automated biomanufacturing.

Consumables and Accessories represent 10%, with culture media and reagents being critical for consistent bioprocess performance.

Others (Osmometers, Incubators, etc.) capture 5%, serving specialized applications in R&D and quality control.

By Consumables and Accessories :
Culture Media lead with 55% share, as optimized media formulations are crucial for cell viability, yield, and product quality in bioproduction.

Reagents account for 35%, including buffers, enzymes, and detection agents essential for various bioprocessing steps.

Other Consumables (filters, tubing, sensors) represent 10%, supporting equipment operation and single-use system integrity.

By Application :
Monoclonal Antibodies (mAbs) lead with 40% share, fueled by their expanding therapeutic use in oncology, immunology, and chronic diseases.

Recombinant Proteins account for 25%, driven by demand for hormones, enzymes, and therapeutic proteins.

Vaccines represent 20%, with sustained investment in both traditional and novel vaccine platforms post-pandemic.

Antibiotics hold 10%, utilizing fermentation based production for next-generation antimicrobials.

Others (cell and gene therapies, biosimilars) capture 5%, the fastest growing segment due to technological innovation.

By End-User :
Biopharmaceutical Companies dominate with 50% share, investing heavily in in-house manufacturing for core biologic products.

Contract Manufacturing Organizations (CMOs/CDMOs) hold 30%, experiencing rapid growth as outsourcing of bioproduction increases.

Academic and Research Institutes account for 15%, driving early stage process development and innovation.

Others (diagnostic labs, food/beverage bio-production) represent 5%, applying bioprocess techniques in adjacent industries.

☛ Competitive Landscape:
The market is highly competitive and consolidated, with key players focusing on portfolio expansion, strategic partnerships, and technological innovation to secure market share.

Thermo Fisher Scientific Inc. and Cytiva (Danaher) are estimated to hold leading positions, leveraging their comprehensive, end-to-end bioprocessing portfolios.

Sartorius AG commands a strong share through its focused offerings in fermentation, fluid management, and analytical technologies.

Merck KGaA is a major player with a robust presence in both equipment and critical consumables like cell culture media.

Repligen Corporation has seen significant growth as a pure-play supplier of key technologies for filtration, chromatography, and process analytics.

Other notable players include Roche Diagnostics, Solida Biotech, Advanced Instruments, and ELITechGroup.

➠ Purchase this report before year-end and unlock an exclusive 30% discount:

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=bioprocess-technology-market?praneetha
(Purchase 2 or more Reports and get 50% Discount)

☛ Regional Analysis:
North America :
North America leads the global market with 40% share, attributed to the strong presence of major biopharmaceutical companies, substantial R&D funding, and early adoption of advanced bioprocessing technologies.

Europe :
Europe holds a significant 30% share, supported by a robust biotechnology sector, favorable government initiatives, and a dense network of CDMOs.

Asia-Pacific :
Asia-Pacific is projected to be the fastest-growing region, accounting for 25% of the market, driven by increasing investments in biomanufacturing capacity, lower production costs, and a burgeoning biosimilars market in countries like China, India, and South Korea.

South America, the Middle East, and Africa collectively represent emerging markets with growing investments in healthcare infrastructure and local vaccine production capabilities.

➠ Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?praneetha

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Market Access Snapshots
✅ Emerging Risks & Market Volatility Analysis
✅ Quarterly Updated Reports
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Company Name: DataM Intelligence 4Market Research LLP
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com/

DataM Intelligence is a global Market Research and Consulting firm providing comprehensive business insights and end-to-end solutions from research to consulting. We deliver actionable intelligence across 6,300+ reports spanning 40+ domains, empowering over 200 companies in 50+ countries. Our focus is on enabling clients to make data driven decisions through robust methodologies, strategic foresight, and real-time market intelligence.

This release was published on openPR.